OncoArendi Therapeutics

About:

OncoArendi Therapeutics specializes in developing and commercializing of therapeutics for neoplastic and inflammatory diseases.

Website: http://www.oncoarendi.com

Twitter/X: oncoarendi

Top Investors: National Center for Research & Development, New Europe Ventures, LLC, Medical University of Warsaw, Michał Sołowow

Description:

OncoArendi Therapeutics is a biopharmaceutical company devoted to finding, creating, and marketing treatments for inflammatory and cancerous conditions. The Company's business strategy is solely centered on the discovery and development of new drugs, and it leverages its strengths in medicinal chemistry and preclinical biology as well as research partnerships with public intellectuals in particular disease areas.

Total Funding Amount:

60.6M PLN

Headquarters Location:

Wysokie Mazowieckie, Podlaskie, Poland

Founded Date:

2012-01-01

Founders:

Jacek Olczak

Number of Employees:

101-250

Last Funding Date:

2017-03-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai